PuSH - Publikationsserver des Helmholtz Zentrums München: Pleiotropic effects of <em>MORC2</em> derive from its epigenetic signature.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Peymani, F. ; Ebihara, T. ; Smirnov, D. ; Kopajtich, R. ; Ando, M.* ; Bertini, E.* ; Carrozzo, R.* ; Diodato, D.* ; Distelmaier, F.* ; Fang, F.* ; Ghezzi, D.* ; Hempel, M.* ; Iwanicka-Pronicka, K.* ; Klopstock, T.* ; Stenton, S. ; Lamperti, C.* ; Liu, Z.* ; Murtazina, A.* ; Okamoto, Y.* ; Okazaki, Y.* ; Piekutowska-Abramczuk, D.* ; Rötig, A.* ; Ryzhkova, O.* ; Schlein, C.* ; Shagina, O.* ; Takashima, H.* ; Tsygankova, P.G.* ; Zech, M. ; Meitinger, T.* ; Shimura, M. ; Murayama, K.* ; Prokisch, H.

Pleiotropic effects of MORC2 derive from its epigenetic signature.

Brain:awaf159 (2025)

Postprint

DOI

PMC

	Open Access Green

Abstract
Metriken
Zusatzinfos

Heterozygous missense mutations in MORC2 have been implicated in various clinical entities, ranging from early-onset neurodevelopmental disorders to late-onset neuropathies. The mechanism underlying the phenotypic heterogeneity and pleiotropic effects of MORC2 has remained elusive. Here, we analyzed blood and fibroblast DNA methylation, transcriptomes, proteomes, and phenotypes of 53 MORC2 patients. We identified a MORC2-specific DNA methylation episignature that is universal across all MORC2-associated phenotypes and conserved across different tissues. The MORC2 episignature consists mainly of DNA hypermethylation in promoter regions, leading to transcriptional repression of target genes resulting in a MORC2-specific RNA signature. Concomitant downregulation of three disease-associated genes -ERCC8, NDUFAF2, and FKTN- at different levels mirrors the variable biochemical defects and clinical manifestations observed in MORC2 patients. Silencing of NDUFAF2 accounts for the Leigh syndrome manifestation, whereas dysmorphic features are due to the repression of ERCC8. Overall, we showed that pathogenic MORC2 variants cause specific episignature, whereby methylation level variability and its repression impact on target genes explains the pleiotropy and predicts phenotypic heterogeneity in MORC2-related disorders. We predict that epigenetic variation may underlie pleiotropy in other Mendelian disorders.

Impact Factor

Scopus SNIP

Altmetric

11.700

0.000